FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia

The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news